[1]
G. A. Parra, H. H. Lindarte, and A. F. Rubio, “Over optimum response to PCSK-9 inhibitors: ¿is it mandatory to supply them every 2 weeks?, about a case”, Rev.ACE, vol. 7, no. 1, pp. 43–44, Apr. 2020.